Effectors enabling adaptation to mitochondrial complex I loss in Hürthle cell carcinoma
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA951766 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR24053355.fastq.gz | Fastqsanger.gz | |||
| SRR24053355_1.fastq.gz | Fastqsanger.gz | |||
| SRR24053355_2.fastq.gz | Fastqsanger.gz | |||
| SRR24053356.fastq.gz | Fastqsanger.gz | |||
| SRR24053356_1.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 126 |
Similar Datasets
Project description:Oncocytic (Hürthle cell) carcinoma of the thyroid (HCC) is genetically characterized by complex I mitochondrial DNA mutations and widespread chromosomal losses. Here, we utilize RNA sequencing and metabolomics to identify candidate molecular effectors activated by these genetic drivers. We find glutathione biosynthesis, amino acid metabolism, mitochondrial unfolded protein response, and lipid peroxide scavenging to be increased in HCC. A CRISPR-Cas9 knockout screen in a new HCC model reveals which pathways are key for fitness, and highlights loss of GPX4, a defense against lipid peroxides and ferroptosis, as a strong liability. Rescuing complex I redox activity with the yeast NADH dehydrogenase (NDI1) in HCC cells diminishes ferroptosis sensitivity, while inhibiting complex I in normal thyroid cells augments ferroptosis induction. Our work demonstrates unmitigated lipid peroxide stress to be an HCC vulnerability that is mechanistically coupled to the genetic loss of mitochondrial complex I activity.SignificanceHCC harbors abundant mitochondria, mitochondrial DNA mutations, and chromosomal losses. Using a CRISPR-Cas9 screen inspired by transcriptomic and metabolomic profiling, we identify molecular effectors essential for cell fitness. We uncover lipid peroxide stress as a vulnerability coupled to mitochondrial complex I loss in HCC. See related article by Frank et al., p. 1884. This article is highlighted in the In This Issue feature, p. 1749.
| S-EPMC10401073 | biostudies-literature
Project description:We report the results of bulk RNA-seq from human Hürthle cell carcinoma (HCC) samples and matched normal thyroids. The bulk RNA-seq data reveals the molecular programs that are activated in HCC. These activated programs include mTOR and Myc signaling, the mitochondrial unfolded protein response, lipid peroxide scavenging, and amino acid biosynthesis.
2023-11-13 | GSE228870 | GEO
Project description:Loss of heterozygosity drives adaptation in hybrid yeast
| PRJNA376031 | ENA
Project description:CGH arrays for Smukowski Heil, et al MBE 2017. Hybridization is often considered maladaptive, but sometimes hybrids can invade new ecological niches and adapt to novel or stressful environments better than their parents. The genomic changes that occur following hybridization that facilitate genome resolution and/or adaptation are not well understood. Here, we address these questions using experimental evolution of de novo interspecific hybrid yeast Saccharomyces cerevisiae x Saccharomyces uvarum and their parentals. We evolved these strains in nutrient limited conditions for hundreds of generations and sequenced the resulting cultures to identify genomic changes. Analysis of 16 hybrid clones and 16 parental clones identified numerous point mutations, copy number changes, and loss of heterozygosity events, including species biased amplification of nutrient transporters. We focused on a particularly interesting example, in which we saw repeated loss of heterozygosity at the high affinity phosphate transporter gene PHO84 in both intra- and interspecific hybrids. Using allele replacement methods, we tested the fitness of different alleles in hybrid and S. cerevisiae strain backgrounds and found that the loss of heterozygosity is indeed the result of selection on one allele over the other in both S. cerevisiae and the hybrids. This is an example where hybrid genome resolution is driven by positive selection on existing heterozygosity, and demonstrates that even infrequent outcrossing may have lasting impacts on adaptation.
2017-02-21 | GSE95086 | GEO
Project description:During acute oxidative phosphorylation (OXPHOS) dysfunction, the reverse activity of succinate dehydrogenase (Complex II) maintains the redox state of the Coenzyme Q pool by utilizing either fumarate or oxygen as terminal electron acceptors. The tendency for one over another has been suggested to be tissue specific. We identified the action of SDHAF2 protein, a Complex II assembly factor that enhances the flavination of catalytic subunit SDHA, as critical for metabolic adaptation during Complex III dysfunction in HEK293T cells. Loss of SDHAF2 during Complex III inhibition led to a net reductive TCA cycle from loss of succinate oxidation, loss of SDHA active site derived reactive oxygen species (ROS)-signaling, insufficient adaptation to glycolysis, and a severe growth impairment. Cell lines adapted to glycolysis did not accumulate SDHAF2 upon Coenzyme Q-pool stress, exhibited a net reductive TCA cycle and mild growth phenotypes with or without SDHAF2 being present. Thus, our study reveals how Complex II assembly controls a balance between dynamics of TCA cycle directionality, protection from Q-pool stress, and an ability to utilize ROS-meditated signaling to overcome acute OXPHOS dysfunction in cells reliant on mitochondrial respiration.
2025-06-06 | PXD064658 | Pride
Project description:During acute oxidative phosphorylation (OXPHOS) dysfunction, the reverse activity of succinate dehydrogenase (Complex II) maintains the redox state of the Coenzyme Q pool by utilizing either fumarate or oxygen as terminal electron acceptors. The tendency for one over another has been suggested to be tissue specific. We identified the action of SDHAF2 protein, a Complex II assembly factor that enhances the flavination of catalytic subunit SDHA, as critical for metabolic adaptation during Complex III dysfunction in HEK293T cells. Loss of SDHAF2 during Complex III inhibition led to a net reductive TCA cycle from loss of succinate oxidation, loss of SDHA active site derived reactive oxygen species (ROS)-signaling, insufficient adaptation to glycolysis, and a severe growth impairment. Cell lines adapted to glycolysis did not accumulate SDHAF2 upon Coenzyme Q-pool stress, exhibited a net reductive TCA cycle and mild growth phenotypes with or without SDHAF2 being present. Thus, our study reveals how Complex II assembly controls a balance between dynamics of TCA cycle directionality, protection from Q-pool stress, and an ability to utilize ROS-meditated signaling to overcome acute OXPHOS dysfunction in cells reliant on mitochondrial respiration.
2025-06-06 | PXD064653 | Pride
Project description:During acute oxidative phosphorylation (OXPHOS) dysfunction, the reverse activity of succinate dehydrogenase (Complex II) maintains the redox state of the Coenzyme Q pool by utilizing either fumarate or oxygen as terminal electron acceptors. The tendency for one over another has been suggested to be tissue specific. We identified the action of SDHAF2 protein, a Complex II assembly factor that enhances the flavination of catalytic subunit SDHA, as critical for metabolic adaptation during Complex III dysfunction in HEK293T cells. Loss of SDHAF2 during Complex III inhibition led to a net reductive TCA cycle from loss of succinate oxidation, loss of SDHA active site derived reactive oxygen species (ROS)-signaling, insufficient adaptation to glycolysis, and a severe growth impairment. Cell lines adapted to glycolysis did not accumulate SDHAF2 upon Coenzyme Q-pool stress, exhibited a net reductive TCA cycle and mild growth phenotypes with or without SDHAF2 being present. Thus, our study reveals how Complex II assembly controls a balance between dynamics of TCA cycle directionality, protection from Q-pool stress, and an ability to utilize ROS-meditated signaling to overcome acute OXPHOS dysfunction in cells reliant on mitochondrial respiration.
2025-06-06 | PXD064649 | Pride
Project description:During acute oxidative phosphorylation (OXPHOS) dysfunction, the reverse activity of succinate dehydrogenase (Complex II) maintains the redox state of the Coenzyme Q pool by utilizing either fumarate or oxygen as terminal electron acceptors. The tendency for one over another has been suggested to be tissue specific. We identified the action of SDHAF2 protein, a Complex II assembly factor that enhances the flavination of catalytic subunit SDHA, as critical for metabolic adaptation during Complex III dysfunction in HEK293T cells. Loss of SDHAF2 during Complex III inhibition led to a net reductive TCA cycle from loss of succinate oxidation, loss of SDHA active site derived reactive oxygen species (ROS)-signaling, insufficient adaptation to glycolysis, and a severe growth impairment. Cell lines adapted to glycolysis did not accumulate SDHAF2 upon Coenzyme Q-pool stress, exhibited a net reductive TCA cycle and mild growth phenotypes with or without SDHAF2 being present. Thus, our study reveals how Complex II assembly controls a balance between dynamics of TCA cycle directionality, protection from Q-pool stress, and an ability to utilize ROS-meditated signaling to overcome acute OXPHOS dysfunction in cells reliant on mitochondrial respiration.
2025-06-06 | PXD064675 | Pride
Project description:Magnaporthe oryzae, the fungus causing rice blast disease, deploys effectors to manipulate host immunity. Apoplastic effectors are secreted conventionally, whereas cytoplasmic effectors are deployed into the biotrophic interfacial complex (BIC) via the unconventional protein secretion (UPS) pathway. Using reverse genetics and live-cell imaging, we previously showed that the translation of cytoplasmic (but not apoplastic) effector mRNAs relies on efficient decoding of AA-ending codons by the Uba4-dependent thiolation of wobble uridine-34 (s2U34) in cognate tRNAs. Loss of UBA4 abolished cytoplasmic effector secretion. Synonymous AA- to AG-ending codon changes in PWL2 mRNA and (we show here) AVR-Pik mRNA restored cytoplasmic effector production and secretion in Δuba4 strains. In WT, expressing recoded PWL2 or AVR-Pik led to the loss of translational speed control, massive protein production, and super-secretion into the BIC, which destabilized, abolishing infection. In PWL2, mutational analysis shows only one AA-ending codon is required for optimizing translation speed and maintaining BIC integrity, highlighting how codon usage choice on fine scales underpins the success of the M. oryzae-host rice plant interaction. We also show here how cytoplasmic effector secretion from other host-infecting M. oryzae lineages is similarly subjected to Uba4-dependent codon control, indicating it is a conserved, fundamental principle of host infection shaping effector evolution.
2025-11-17 | GSE297821 | GEO
Project description:Injection of effectors via a type III secretion system (T3SS) is an infection strategy shared by many Gram-negative bacterial pathogens. While individual T3SS effectors are well characterized, their network-level organization and the distinction between core and accessory effectors remain incompletely understood. Here, we systematically dissect the T3SS effector network from Citrobacter rodentium (CR), identifying a subset of 12 accessory effectors that, while dispensable for colonization, significantly alter infection outcomes. A strain lacking these effectors (CRM12) remained virulent in susceptible hosts yet resulted in reduced epithelial barrier damage, inflammation and immune cell infiltration in resistant mouse hosts. Deep proteomic analysis specifically targeting CR-attached colonic epithelial cells revealed that, despite lacking 39% of its effector repertoire, infection with CRM12 results in similar changes to global protein expression as seen in mice infected with the wild-type strain, though key regulators of barrier disruption were differentially expressed. Using a host model with impaired barrier repair, we confirmed that accessory effectors shape infection dynamics without significantly impacting virulence. This study thus refines the concept of core and accessory effectors, providing a basis for further studies into effector-driven host adaptation.
2025-04-16 | PXD062886 | Pride